Syra Health to Present at NobleCon20
Syra Health (NASDAQ: SYRA) announced its participation in the Noble Financial Capital Markets 20th Annual Equity Conference (NobleCon20) scheduled for December 3-4 in Boca Raton, Florida. CEO Dr. Deepika Vuppalanchi will present on December 3 at 2:00 p.m. ET, showcasing the company's healthcare solutions focused on mental health crisis, chronic conditions, and child welfare challenges.
The presentation will be followed by a fireside chat and one-on-one investor meetings. CFO Priya Prasad will also attend the event. The company reports strong revenue growth and expanding market presence, positioning itself to meet increasing demand for innovative healthcare solutions.
Syra Health (NASDAQ: SYRA) ha annunciato la sua partecipazione al 20掳 Annual Equity Conference di Noble Financial Capital Markets (NobleCon20), previsto per il 3-4 dicembre a Boca Raton, Florida. Il CEO Dr. Deepika Vuppalanchi presenter脿 il 3 dicembre alle 14:00 ET, illustrando le soluzioni sanitarie dell'azienda focalizzate sulla crisi della salute mentale, sulle condizioni croniche e sulle sfide nel benessere infantile.
La presentazione sar脿 seguita da una chiacchierata informale e da incontri individuali con gli investitori. Anche il CFO Priya Prasad parteciper脿 all'evento. L'azienda riporta una forte crescita dei ricavi e un'ampia presenza nel mercato, posizionandosi per soddisfare la crescente domanda di soluzioni sanitarie innovative.
Syra Health (NASDAQ: SYRA) anunci贸 su participaci贸n en la 20陋 Conferencia Anual de Capital de Noble Financial Markets (NobleCon20), programada para el 3 y 4 de diciembre en Boca Raton, Florida. La CEO, Dra. Deepika Vuppalanchi, presentar谩 el 3 de diciembre a las 2:00 p.m. ET, mostrando las soluciones de atenci贸n m茅dica de la empresa centradas en crisis de salud mental, condiciones cr贸nicas y retos en el bienestar infantil.
La presentaci贸n ser谩 seguida por una charla informal y reuniones individuales con inversores. La CFO Priya Prasad tambi茅n asistir谩 al evento. La compa帽铆a informa de un s贸lido crecimiento de ingresos y una creciente presencia en el mercado, posicion谩ndose para satisfacer la demanda en aumento de soluciones de atenci贸n m茅dica innovadoras.
Syra Health (NASDAQ: SYRA)電� 頂岆毽嫟 欤� 氤挫勾 霟啢鞐愳劀 12鞗� 3-4鞚检棎 鞓堨爼霅� 雲鸽笖 韺岇澊雮胳厹 旌愴敿韮� 毵堨紦 20須� 鞐半 欤检嫕 旎嵓霟办姢 (NobleCon20)鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. CEO Dr. Deepika Vuppalanchi電� 12鞗� 3鞚� 鞓ろ泟 2鞁滌棎 氚滍憸頃橃棳 鞝曥嫚 瓯搓皶 鞙勱赴, 毵岇劚 歆堩櫂, 鞎勲彊 氤奠 氍胳牅鞐� 欷戩爯鞚� 霊� 須岇偓鞚� 鞚橂 靻旊（靺橃潉 靻岅皽頃� 鞓堨爼鞛呺媹雼�.
氚滍憸 鞚错泟鞐愲姅 鞛愳湢搿滌毚 雽�頇� 鞁滉皠鞚� 臧�歆�氅�, 鞚茧寑鞚� 韴瀽鞛� 氙疙寘霃� 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. CFO Priya Prasad霃� 鞚� 頄夓偓鞐� 彀胳劃頃╇媹雼�. 須岇偓電� 臧曤牓頃� 靾橃澋 靹膘灔瓿� 鞁滌灔 臁挫灛臧� 頇曤寑毳� 氤搓碃頃橁碃 鞛堨溂氅�, 順侅嫚鞝侅澑 鞚橂 靻旊（靺橃棎 雽�頃� 歃濌皜頃橂姅 靾橃殧毳� 於╈”頃� 靾� 鞛堧弰搿� 韽靺旊嫕頃橁碃 鞛堨姷雼堧嫟.
Syra Health (NASDAQ: SYRA) a annonc茅 sa participation 脿 la 20e Conf茅rence Annuelle sur les Actions de Noble Financial Capital Markets (NobleCon20), pr茅vue les 3 et 4 d茅cembre 脿 Boca Raton, Floride. Le PDG Dr. Deepika Vuppalanchi pr茅sentera le 3 d茅cembre 脿 14h00 ET, mettant en avant les solutions de sant茅 de l'entreprise ax茅es sur la crise de la sant茅 mentale, les maladies chroniques et les d茅fis du bien-锚tre des enfants.
La pr茅sentation sera suivie d'une discussion informelle et de r茅unions individuelles avec les investisseurs. La CFO Priya Prasad assistera 茅galement 脿 l'茅v茅nement. L'entreprise rapporte une forte croissance des revenus et une pr茅sence croissante sur le march茅, se positionnant pour r茅pondre 脿 la demande croissante de solutions de sant茅 innovantes.
Syra Health (NASDAQ: SYRA) hat seine Teilnahme an der 20. j盲hrlichen Eigenkapitalkonferenz von Noble Financial Capital Markets (NobleCon20), die f眉r den 3. und 4. Dezember in Boca Raton, Florida, geplant ist, bekannt gegeben. CEO Dr. Deepika Vuppalanchi wird am 3. Dezember um 14:00 Uhr ET pr盲sentieren und dabei die Gesundheitsl枚sungen des Unternehmens pr盲sentieren, die sich auf Krisen im Bereich der psychischen Gesundheit, chronische Erkrankungen und Herausforderungen im Bereich des Kindeswohls konzentrieren.
Der Pr盲sentation folgt ein informelles Gespr盲ch sowie Einzelgespr盲che mit Investoren. CFO Priya Prasad wird ebenfalls an der Veranstaltung teilnehmen. Das Unternehmen meldet ein starkes Umsatzwachstum und eine zunehmende Marktpr盲senz, wodurch es sich positioniert, um der steigenden Nachfrage nach innovativen Gesundheitsl枚sungen gerecht zu werden.
- None.
- None.
Syra Health CEO, Dr. Deepika Vuppalanchi, will present at the prestigious event, which highlights emerging growth companies. Dr. Vuppalanchi will deliver the Company's presentation on December 3 at 2:00 p.m. ET. The presentation will highlight Syra Health's healthcare solutions, designed to address the growing mental health crisis, other chronic conditions, and child welfare challenges, while delivering both improved patient outcomes and public health advancements. These innovative approaches are particularly impactful in regions where the demand for accessible, affordable, and high-quality care is rapidly increasing, reflecting Syra's commitment to fostering healthier communities and driving meaningful change.
"We are excited to present Syra Health's innovations at the Noble Conference," said Dr. Vuppalanchi. "This platform provides an excellent opportunity to engage with investors to discuss how our solutions are transforming healthcare, improving outcomes, and driving access and affordability across the system."
Following the presentation, Dr. Vuppalanchi will engage in a fireside chat, offering further insights into Syra Health's strategy and vision for the future. In addition to the presentation and fireside chat, Dr. Vuppalanchi will participate in one-on-one meetings with investors. Syra Health's CFO, Priya Prasad, will also attend the event.
Syra Health's financial outlook is robust, with strong revenue growth and an expanding market presence. The Company is well-positioned to capitalize on the increasing demand for its innovative healthcare solutions and to continue driving value for stakeholders.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit .
Forward-Looking Statements聽
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For Investor or Media Inquiries:
Christine Drury
IR/PR
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:
SOURCE Syra Health
FAQ
When is Syra Health (SYRA) presenting at NobleCon20?
What healthcare solutions will Syra Health (SYRA) discuss at NobleCon20?
Who will represent Syra Health (SYRA) at the Noble Conference 2023?
What is the current financial outlook for Syra Health (SYRA)?
